High Throughput Screening (HTS) Market by Technology, Applications & by End Users - Forecast to 2018

DUBLIN, Feb. 12, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/5vvhtj/high_throughput) has announced the addition of the "High Throughput Screening (HTS) Market by Technology, Applications & by End Users - Forecast to 2018" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

In recent years, the high throughput screening (HTS) market has witnessed a large number of technological advancements, which has resulted in an increase in the rate of adoption of HTS in laboratories. The global HTS market was valued at $13,736 million in 2013 and is expected to reach $19,627 million by 2018, at a CAGR of 7.4%. The HTS market is broadly classified into five segments, namely, technologies, products, applications, end users, and geography.

The technology market is sub-divided into ultra high throughput screening, cell-based assays, lab-on-a chip, label-free technology, and bioinformatics. The cell-based assays segment dominated the HTS market in 2013, followed by the lab-on-a-chip segment. The HTS products market is broadly categorized into instruments, consumables/reagents, and software and services. The consumables/reagents segment dominated this market in 2013, with a market share of around 57%. The applications market is segmented into target identification, primary screening, toxicology, stem cell biology, and others. Target identification dominated the HTS applications market in 2013, followed by the primary screening market. The HTS market by end user is broadly categorized into pharmaceutical companies, biotechnology companies, academic and government institutes, contract research organizations (CROs), and others. The pharmaceuticals segment dominated the market in 2013, with a market share of around 48%.

The major factors driving the growth of the HTS market are technological innovations, open innovation models adopted by pharmaceutical companies, increasing drug discovery initiatives by academic institutions, and huge capital investments in HTS technology by organizations. Moreover, the presence of a large untapped market in emerging countries and growth in outsourcing of drug discovery services especially in China and India are the various factors that are expected to provide growth opportunities for players in this market. However, the capital intensive nature of HTS and difficulties in assay development for novel target classes are the factors curbing the growth of this market.

The global HTS market is dominated by North America, followed by Europe. North America will continue to lead the global HTS market in the forecast period. Over the next five years, Asia is expected to grow at the highest CAGR of 9.1%. Factors such as growth in investments as well as the growth in the outsourcing industry, and favorable economic conditions are responsible for the high growth of the HTS market in Asia.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Premium Insights

4 Market Overview

5 High Throughput Screening Market, By Technology

6 High Throughput Screening Market, By Product

7 Global High Throughput Screening Market, By Application

8 Global High Throughput Screening Market, By End Users

9 Geographic Analysis

10 Competitive Landscape

11 Company Profiles

Companies Mentioned:

• Agilent Technologies, Inc.
• Aurora Biomed
• Axxam Spa
• Beckman Coulter, Inc. (A Subsidiary Of Danaher)
• Bio-Rad Laboratories
• Biofocus Dpi Ltd.
• Intellicyt Corporation
• Luminex Corporation
• Perkinelmer, Inc.
• Sigma Aldrich Corporation
• Tecan Group Ltd.
• Thermo Fisher Scientific, Inc.

For more information visit http://www.researchandmarkets.com/research/5vvhtj/high_throughput

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net